Entire Cohort (n = 278) | Adverse outcome at 30d | 6 year Mortality |
---|---|---|
OR (95% CI); p-value | HR (95% CI); p-value | |
Tyrosinea | ||
Univariate | 3.30 (0.63 to 17.36), p = 0.159 | 1.88 (0.90 to 3.91), p = 0.093 |
Multivariateb | 0.84 (0.15 to 4.65), p = 0.841 | 1.58 (0.72 to 3.47), p = 0.256 |
AUROC | 0.55 (0.44 to 0.66) | 0.60 (0.54 to 0.67) |
Tyr-NO2a | ||
Univariate | 0.65 (0.35 to 1.20), p = 0.167 | 0.96 (0.73 to 1.27), p = 0.778 |
Multivariateb | 0.44 (0.20 to 0.96), p = 0.039 | 0.81 (0.6 to 1.1), p = 0.181 |
AUROC | 0.43 (0.31 to 0.56) | 0.50 (0.42 to 0.58) |
Ratio Tyr-NO2/Tyrosine | ||
Univariate | 0.91 (0.81 to 1.02), p = 0.098 | 0.99 (0.95 to 1.02), p = 0.457 |
Multivariateb | 0.98 (0.97 to 0.99), p = 0.043 | 1.00 (0.99 to 1.00), p = 0.216 |
AUROC | 0.42 (0.30 to 0.53) | 0.48 (0.40 to 0.56) |